Consistently, DLEU1 has been demonstrated to be dysregulated and exerts an oncogenic function in tumors such as oral squamous cell carcinoma [19], glioma [32], endometrial cancer [33], and non-small-cell lung cancer [34]. The gene discussed is DLEU1; the disease is endometrial cancer.